Network origin in John Magee first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Magee via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| INVIVYD, INC. | Biotechnology | Director of Finance/CFO Investor Relations Contact Human Resources Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| CUE BIOPHARMA, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| INDIVIOR PLC | Pharmaceuticals: Major | Director/Board Member | |
Commonwealth National Fund, Inc.
 Commonwealth National Fund, Inc. Financial ConglomeratesFinance Commonwealth National Fund, Inc. functions as an investment fund. The private company is based in Stuart. | Financial Conglomerates | Director/Board Member | |
| ALKERMES PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
GE UK Group
 GE UK Group MiscellaneousMiscellaneous Part of GE Aerospace, GE UK Group is an investment holding company. GE UK Group is based in Altrincham, UK. The British company was founded in 2008. The CEO is Kevin Michael O'Neill. | Miscellaneous | Chief Tech/Sci/R&D Officer | |
| UMass Chan Medical School | College/University | Doctorate Degree | |
| GE Healthcare Medical Diagnostics | Chief Tech/Sci/R&D Officer | ||
| University of Oxford | College/University | Graduate Degree | |
| Babson College | College/University | Masters Business Admin | |
| Boston University | College/University | Undergraduate Degree | |
| DYAX CORP. | Pharmaceuticals: Major | Compliance Officer | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Compliance Officer | |
| Suffolk University Law School | College/University | Graduate Degree | |
| Sanofi Corp. | Corporate Officer/Principal | ||
| University of Pennsylvania | College/University | Undergraduate Degree | |
| Virginia Polytechnic Institute & State University | College/University | Undergraduate Degree | |
Flexion, Inc.
 Flexion, Inc. Information Technology ServicesTechnology Services Flexion, Inc. is an American company that offers services to help businesses with digital transformation, innovative development, and modernization. The private company provides IT staffing and work to improve the efficiency, security, and user experience of their clients' systems. Flexion uses a rigorous agile practice to build flexible solutions that enable their clients' businesses to grow. | Information Technology Services | General Counsel | |
| IMMUNOVANT, INC. | Biotechnology | General Counsel | |
| ATHENAHEALTH, INC | Packaged Software | Corporate Officer/Principal | |
| Washington University School of Law | College/University | Graduate Degree | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | General Counsel | |
| State University of New York at Binghamton | College/University | Undergraduate Degree | |
| TENGION, INC. | Biotechnology | Public Communications Contact | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| KINETA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| RENOVACOR, INC. | Biotechnology | Director of Finance/CFO | |
| IMMUNITYBIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CONFORMIS, INC. | Medical Specialties | Director of Finance/CFO | |
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| ABPRO CORPORATION | Biotechnology | Director/Board Member | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 43 |
| United Kingdom | 4 |
| Switzerland | 2 |
| Ireland | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 14 |
| Commercial Services | 4 |
| Technology Services | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 22 |
| Director of Finance/CFO | 16 |
| Corporate Officer/Principal | 16 |
| Independent Dir/Board Member | 13 |
| Comptroller/Controller/Auditor | 9 |
Most connected contacts
| Insiders | |
|---|---|
| Fred Driscoll | 21 |
| David Arkowitz | 20 |
| Mark Stejbach | 9 |
| Mark Levine | 8 |
| Adam L. Muzikant | 7 |
| Yamo Deniz | 7 |
| Mark Fraga | 5 |
| Carolyn Beaty Scimemi | 4 |
| Julie Green | 4 |
| Kerri-Ann Millar | 3 |
| Scott A. Young | 2 |
- Stock Market
- Insiders
- John Magee
- Company connections
